| Amanda Berbert, MD | |
|
708 E Wythe Creek Ct Ste 103, Kuna, ID 83634 | |
| (208) 922-5130 | |
| Not Available |
| Full Name | Amanda Berbert |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 9 Years |
| Location | 708 E Wythe Creek Ct Ste 103, Kuna, Idaho |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134500515 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | M-14288 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Utah Hospitals And Clinics | Salt lake city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Utah Community Physicians Group | 9739403569 | 257 |
News Archive
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has extended the PDUFA goal date for its review of the New Drug Application (NDA) for Fampridine-SR to January 22, 2010. The original Prescription Drug User Fee Act (PDUFA) date for this priority review application was October 22, 2009.
Abbott today announced it has received U.S. Food and Drug Administration approval for the XIENCE nano Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease in small vessels.
National Health Partners, Inc., a leading provider of unique discount healthcare membership programs, is pleased to announce today that the Company has achieved positive earnings for the quarter ended September 30, 2010 compared to a loss of $522,542 for the same period last year. Revenues for the 3rd quarter grew 12.3% over the same period last year.
Market leaders in temperature controlled microscopy, Linkam Scientific Instruments, have been chosen as suppliers of warm stages to a number of laboratories in the UK for sperm assessment.
› Verified 5 days ago
| Entity Name | University Of Utah Community Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598169203 PECOS PAC ID: 9739403569 Enrollment ID: O20150126002118 |
News Archive
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has extended the PDUFA goal date for its review of the New Drug Application (NDA) for Fampridine-SR to January 22, 2010. The original Prescription Drug User Fee Act (PDUFA) date for this priority review application was October 22, 2009.
Abbott today announced it has received U.S. Food and Drug Administration approval for the XIENCE nano Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease in small vessels.
National Health Partners, Inc., a leading provider of unique discount healthcare membership programs, is pleased to announce today that the Company has achieved positive earnings for the quarter ended September 30, 2010 compared to a loss of $522,542 for the same period last year. Revenues for the 3rd quarter grew 12.3% over the same period last year.
Market leaders in temperature controlled microscopy, Linkam Scientific Instruments, have been chosen as suppliers of warm stages to a number of laboratories in the UK for sperm assessment.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Berbert, MD 777 N Raymond St, Boise, ID 83704-9251 Ph: () - | Amanda Berbert, MD 708 E Wythe Creek Ct Ste 103, Kuna, ID 83634 Ph: (208) 922-5130 |
News Archive
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has extended the PDUFA goal date for its review of the New Drug Application (NDA) for Fampridine-SR to January 22, 2010. The original Prescription Drug User Fee Act (PDUFA) date for this priority review application was October 22, 2009.
Abbott today announced it has received U.S. Food and Drug Administration approval for the XIENCE nano Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease in small vessels.
National Health Partners, Inc., a leading provider of unique discount healthcare membership programs, is pleased to announce today that the Company has achieved positive earnings for the quarter ended September 30, 2010 compared to a loss of $522,542 for the same period last year. Revenues for the 3rd quarter grew 12.3% over the same period last year.
Market leaders in temperature controlled microscopy, Linkam Scientific Instruments, have been chosen as suppliers of warm stages to a number of laboratories in the UK for sperm assessment.
› Verified 5 days ago
Molly M Mccormick, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 708 E Wythe Creek Ct Ste 103, Kuna, ID 83634 Phone: 208-922-5130 Fax: 208-375-2217 | |
Darrel Robert Porr, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 708 E Wythe Creek Ct Ste 103, Kuna, ID 83634 Phone: 208-922-5130 Fax: 208-922-5132 | |
Justin Loren Parkinson, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 757 E Wythe Creek Ct, Kuna, ID 83634 Phone: 208-302-6500 Fax: 208-302-6535 | |
Courtland Reid Carbol, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 206 S Sunniva Ave, Kuna, ID 83634 Phone: 208-406-8941 Fax: 208-238-8888 | |
Sarah G. Gerrish, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 708 E Wythe Creek Ct Ste 103, Kuna, ID 83634 Phone: 208-922-5130 Fax: 208-375-2217 | |
Dr. Michael W Foutz, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 943 Linder Rd, Suite 103, Kuna, ID 83634 Phone: 208-922-3355 Fax: 208-922-9499 |